3.60
price up icon5.88%   0.20
after-market アフターアワーズ: 3.61 0.010 +0.28%
loading
前日終値:
$3.40
開ける:
$3.37
24時間の取引高:
380.94K
Relative Volume:
0.93
時価総額:
$189.94M
収益:
-
当期純損益:
$-197.68M
株価収益率:
-0.9574
EPS:
-3.76
ネットキャッシュフロー:
$-158.88M
1週間 パフォーマンス:
+4.65%
1か月 パフォーマンス:
-25.00%
6か月 パフォーマンス:
-51.55%
1年 パフォーマンス:
+13.21%
1日の値動き範囲:
Value
$3.26
$3.635
1週間の範囲:
Value
$3.26
$3.8069
52週間の値動き範囲:
Value
$1.92
$11.60

Kodiak Sciences Inc Stock (KOD) Company Profile

Name
名前
Kodiak Sciences Inc
Name
セクター
Healthcare (1166)
Name
電話
650-281-0850
Name
住所
1200 PAGE MILL RD, PALO ALTO, CA
Name
職員
113
Name
Twitter
@kodiaksciences
Name
次回の収益日
2024-11-12
Name
最新のSEC提出書
Name
KOD's Discussions on Twitter

KOD を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
KOD
Kodiak Sciences Inc
3.60 188.89M 0 -197.68M -158.88M -3.76
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.93 25.76B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
445.43 114.53B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.415 40.54M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
84.10 6.44B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.81 65.13B 14.09B 4.50B 2.96B 39.28

Kodiak Sciences Inc Stock (KOD) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-12-09 アップグレード Jefferies Hold → Buy
2024-09-05 開始されました H.C. Wainwright Neutral
2023-12-11 再開されました Goldman Sell
2023-11-17 アップグレード CapitalOne Equal Weight → Overweight
2023-07-27 ダウングレード UBS Buy → Neutral
2023-07-25 ダウングレード Chardan Capital Markets Buy → Neutral
2023-07-25 ダウングレード JP Morgan Neutral → Underweight
2023-07-24 ダウングレード CapitalOne Overweight → Equal Weight
2023-07-24 ダウングレード Jefferies Buy → Hold
2022-11-15 開始されました CapitalOne Overweight
2022-08-02 ダウングレード Citigroup Neutral → Sell
2022-02-24 ダウングレード JP Morgan Overweight → Neutral
2022-02-11 開始されました Goldman Buy
2022-02-02 アップグレード JP Morgan Neutral → Overweight
2021-05-11 アップグレード ROTH Capital Neutral → Buy
2021-03-12 開始されました Evercore ISI Outperform
2021-03-01 ダウングレード Barclays Equal Weight → Underweight
2021-02-17 ダウングレード ROTH Capital Buy → Neutral
2021-01-25 ダウングレード BMO Capital Markets Outperform → Market Perform
2020-12-17 開始されました Berenberg Buy
2020-12-16 開始されました UBS Buy
2020-12-11 開始されました Citigroup Neutral
2020-11-30 ダウングレード JP Morgan Overweight → Neutral
2020-11-16 ダウングレード Morgan Stanley Overweight → Equal-Weight
2020-11-13 ダウングレード Goldman Buy → Neutral
2020-03-31 開始されました BMO Capital Markets Outperform
2020-03-03 開始されました Goldman Buy
2020-02-18 ダウングレード Barclays Overweight → Equal Weight
2020-02-06 開始されました SunTrust Buy
2020-01-08 開始されました ROTH Capital Buy
2020-01-03 開始されました Jefferies Buy
2019-12-24 開始されました JP Morgan Overweight
2019-10-15 繰り返されました Chardan Capital Markets Buy
2019-02-20 開始されました Chardan Capital Markets Buy
2018-10-29 開始されました Barclays Overweight
2018-10-29 開始されました BofA/Merrill Buy
2018-10-29 開始されました Morgan Stanley Overweight
すべてを表示

Kodiak Sciences Inc (KOD) 最新ニュース

pulisher
May 29, 2025

Kodiak Sciences to Present at 2025 Jefferies Global Healthcare C - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Kodiak Sciences Reveals Latest Retinal Disease Breakthroughs at Major Healthcare Conference - Stock Titan

May 29, 2025
pulisher
May 29, 2025

Kodiak Sciences to Present at 2025 Jefferies Global Healthcare Conference - Yahoo Finance

May 29, 2025
pulisher
May 28, 2025

Kodiak Sciences’ SWOT analysis: eye disease biotech stock at crossroads - Investing.com Australia

May 28, 2025
pulisher
May 27, 2025

Kodiak Sciences’ SWOT analysis: eye disease biotech stock at crossroads By Investing.com - Investing.com India

May 27, 2025
pulisher
May 25, 2025

Kodiak Q1 Loss Wider Than Expected, Pipeline Development in Focus - The Globe and Mail

May 25, 2025
pulisher
May 19, 2025

Kodal Minerals Nears Export Permit For Mali Lithium Project - Finimize

May 19, 2025
pulisher
May 15, 2025

Kodiak Sciences Inc Reports Q1 2025 Earnings: EPS of -$1.09 Misses Estimates, No Revenue Reported - GuruFocus

May 15, 2025
pulisher
May 14, 2025

KOD Plans to Unveil Key Developments as Phase 3 Trials Progress - GuruFocus

May 14, 2025
pulisher
May 14, 2025

KOD Plans to Unveil Key Developments as Phase 3 Trials Progress | KOD Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Kodiak Sciences Announces Recent Business Highlights and First Q - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Kodiak Sciences Reports Deeper Q1 Loss: What 3 Key Phase 3 Trials Mean for Future Growth - Stock Titan

May 14, 2025
pulisher
May 14, 2025

Kodiak Sciences (KOD) Projected to Post Earnings on Wednesday - Defense World

May 14, 2025
pulisher
May 13, 2025

Kodiak Sciences Inc. (NASDAQ:KOD) Shares Acquired by Dimensional Fund Advisors LP - Defense World

May 13, 2025
pulisher
May 09, 2025

MetLife Investment Management LLC Makes New $209,000 Investment in Kodiak Sciences Inc. (NASDAQ:KOD) - The AM Reporter

May 09, 2025
pulisher
May 09, 2025

MetLife Investment Management LLC Invests $209,000 in Kodiak Sciences Inc. (NASDAQ:KOD) - Defense World

May 09, 2025
pulisher
May 09, 2025

Wells Fargo & Company MN Sells 2,710 Shares of Kodiak Sciences Inc. (NASDAQ:KOD) - Defense World

May 09, 2025
pulisher
May 07, 2025

Ratio Review: Analyzing Kodiak Sciences Inc (KOD)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX

May 07, 2025
pulisher
May 07, 2025

Retinal vein occlusion Market: Epidemiology, Therapies, - openPR.com

May 07, 2025
pulisher
May 06, 2025

BlackRock, Inc. Reduces Stake in Kodiak Sciences Inc. - GuruFocus

May 06, 2025
pulisher
May 02, 2025

Kodiak Sciences Data at ARVO 2025 Highlight Power and Versatilit - GuruFocus

May 02, 2025
pulisher
May 02, 2025

CND Life Sciences Closes $13.5M Series A Equity Round to Continue Growth and Innovation in Neurodiagnostics - The Malaysian Reserve

May 02, 2025
pulisher
May 01, 2025

Breakthrough Eye Disease Platform: Kodiak Sciences Reveals 7 Major Advances at ARVO 2025 - Stock Titan

May 01, 2025
pulisher
May 01, 2025

Kodiak Sciences Data at ARVO 2025 Highlight Power and Versatility of ABC Platform in Addressing Complex Multifactorial Ocular Diseases - Yahoo Finance

May 01, 2025
pulisher
Apr 30, 2025

Wet Age-Related Macular Degeneration Treatment Market 2034: EMA, PDMA, FDA Approvals, Clinical Trials, Medication, Therapies, NICE Approvals, Prevalence, and Companies by DelveInsight - Barchart.com

Apr 30, 2025
pulisher
Apr 27, 2025

JPMorgan Chase & Co. Increases Holdings in Kodiak Sciences Inc. (NASDAQ:KOD) - Defense World

Apr 27, 2025
pulisher
Apr 24, 2025

Kodiak Sciences Inc [KOD] Shares Rise 9.62 % on Wednesday - knoxdaily.com

Apr 24, 2025
pulisher
Apr 24, 2025

A year in review: Kodiak Sciences Inc (KOD)’s performance in the last year - uspostnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

Insider’s View: Deciphering Kodiak Sciences Inc (KOD)’s Financial Health Through Ratios - DWinneX

Apr 24, 2025
pulisher
Apr 18, 2025

April 2025's Promising Penny Stocks - Yahoo

Apr 18, 2025
pulisher
Apr 18, 2025

Stealth biotech bags rights to VelaVigo bispecific in $440M deal - Fierce Biotech

Apr 18, 2025
pulisher
Apr 17, 2025

AMKR Shares Experience Decline in Value - knoxdaily.com

Apr 17, 2025
pulisher
Apr 17, 2025

Age Related Vision Dysfunction Market to Reach New Heights - openPR.com

Apr 17, 2025
pulisher
Apr 17, 2025

Age Related Vision Dysfunction Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Kodiak Sciences Inc., Outlook Therapeutics, Eye point Pharmaceuticals - The Globe and Mail

Apr 17, 2025
pulisher
Apr 15, 2025

Why Coffee Prices Remain Volatile - The Globe and Mail

Apr 15, 2025
pulisher
Apr 12, 2025

Prudential Financial Inc. Sells 65,400 Shares of Kodiak Sciences Inc. (NASDAQ:KOD) - Defense World

Apr 12, 2025
pulisher
Apr 11, 2025

Wet Age-Related Macular Degeneration Therapeutics Market Size - openPR.com

Apr 11, 2025
pulisher
Apr 09, 2025

Sei Investments Co. Sells 69,599 Shares of Kodiak Sciences Inc. (NASDAQ:KOD) - Defense World

Apr 09, 2025
pulisher
Apr 04, 2025

Kodiak Sciences stock hits 52-week low at $2.15 - Investing.com India

Apr 04, 2025
pulisher
Apr 04, 2025

HC Wainwright Comments on Kodiak Sciences Q2 Earnings - Defense World

Apr 04, 2025
pulisher
Apr 03, 2025

HC Wainwright Forecasts Kodiak Sciences Q1 Earnings - Defense World

Apr 03, 2025
pulisher
Apr 01, 2025

Down -28.08% in 4 Weeks, Here's Why You Should You Buy the Dip in Kodiak Sciences (KOD) - Yahoo Finance

Apr 01, 2025
pulisher
Mar 31, 2025

H.C. Wainwright holds Kodiak Sciences stock at Neutral, $3 target By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

H.C. Wainwright holds Kodiak Sciences stock at Neutral, $3 target - Investing.com

Mar 31, 2025
pulisher
Mar 28, 2025

Kodiak Q4 Loss Narrower Than Expected, Pipeline Development in Focus - MSN

Mar 28, 2025
pulisher
Mar 28, 2025

Charles Schwab Investment Management Inc. Sells 6,758 Shares of Kodiak Sciences Inc. (NASDAQ:KOD) - Defense World

Mar 28, 2025
pulisher
Mar 28, 2025

Kodiak Sciences Advances Retinal Therapies with Promising Pipeline - TipRanks

Mar 28, 2025
pulisher
Mar 27, 2025

Kodiak Sciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 27, 2025

Kodiak Sciences Inc (KOD) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Kodiak Sciences Inc (KOD) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
BORGESON JOHN A.
See Remarks
Jun 12 '24
Sale
2.92
1,558
4,549
179,544
$1.15
price up icon 6.48%
$31.19
price up icon 3.48%
$584.61
price up icon 1.98%
$306.09
price up icon 0.50%
$4.5994
price up icon 2.21%
$490.81
price up icon 0.11%
大文字化:     |  ボリューム (24 時間):